AstraZeneca PLC Stock Forecast for 2023 - 2025 - 2030

Updated on 04/01/2023

Stock Rating
8
Price Target
£155.85
Consensus
Outperform
Downside
-98.61%
Analysts
4
Stock Rating
8
Downside
-98.61%
Analysts
4
Price Target
£155.85

AstraZeneca PLC Stock Forecast and Price Target

AstraZeneca PLC has an average price target of £155.85 recently offered by four notable experts for 2023, which would represent a potential downside of approximately -98.61% from the last closing price in March, 2023 if reached. This potential increase is based on a high estimate of £212.85 and a low estimate of £80.54. If you're looking to buy AstraZeneca PLC stock, you may also want to check out its rivals.

£155.85

-98.61% Downside

Outperform
Outperform

AstraZeneca PLC Fair Value Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's Price has grown in the last two years, jumping from £60.20 to £90.99 – an increase of 51.14%. In the following year, 0 experts forecast AstraZeneca PLC's Fair Value will decrease by 20.32%, to £72.50. In 2030, professionals predict that AstraZeneca PLC's Fair Value will decrease by 17.59%, to £74.98.

2022 Fair Value Forecast
£72.50
2023 Fair Value Forecast
£69.73
2024 Fair Value Forecast
£71.00
2025 Fair Value Forecast
£77.55
2026 Fair Value Forecast
£75.93
2027 Fair Value Forecast
£73.88
2028 Fair Value Forecast
£73.01
2029 Fair Value Forecast
£74.49
2030 Fair Value Forecast
£74.98
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
JNJ Stock Forecast Johnson & Johnson Outperform 10
$154.95 Buy/Sell $181.05 16.49%
LLY Stock Forecast Eli Lilly and Outperform 16
$343.42 Buy/Sell $333.19 16.48%
NOVO B Stock Forecast Novo Nordisk A/S Outperform 10
kr967.50 Buy/Sell kr937.82 0.78%
ABBV Stock Forecast AbbVie Outperform 10
$159.36 Buy/Sell $162.24 3.54%
PFE Stock Forecast Pfizer Inc Outperform 3
$40.79 Buy/Sell $53.97 29.08%

AstraZeneca PLC Revenue Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's Revenue has grown in the last two years, jumping from £24.38B to £37.42B – an increase of 53.45%. In the following year, 0 experts forecast AstraZeneca PLC's Revenue will decrease by 22.04%, to £29.17B. In 2030, professionals predict that AstraZeneca PLC's Revenue will decrease by 18.95%, to £30.33B.

2022 Rev Forecast
£29.17B
2023 Rev Forecast
£28.30B
2024 Rev Forecast
£28.53B
2025 Rev Forecast
£31.44B
2026 Rev Forecast
£30.71B
2027 Rev Forecast
£29.92B
2028 Rev Forecast
£29.50B
2029 Rev Forecast
£30.13B
2030 Rev Forecast
£30.33B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MRK Stock Forecast Merck Outperform 5
$106.38 Buy/Sell $99.57 10.92%
NOVN Stock Forecast Novartis Hold 10
CHF85.77 Buy/Sell CHF103.75 9.89%
ABT Stock Forecast Abbott Laboratories Outperform 10
$101.26 Buy/Sell $121.44 23.44%

AstraZeneca PLC Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, AstraZeneca PLC's Dividend per Share has increased by 2.50%, going from £2.80 to £2.87. According to 0 major analysts, AstraZeneca PLC's Dividend per Share will fall by 1.63% in the next year, reaching £2.82. Professionals believe that By 2030, AstraZeneca PLC's Dividend per Share will fall to £2.82– a 1.57% decrease from its current value.

2022 DPS Forecast
£2.82
2023 DPS Forecast
£2.82
2024 DPS Forecast
£2.81
2025 DPS Forecast
£2.83
2026 DPS Forecast
£2.83
2027 DPS Forecast
£2.82
2028 DPS Forecast
£2.82
2029 DPS Forecast
£2.82
2030 DPS Forecast
£2.82
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BMY Stock Forecast Bristol-Myers Squibb Co Outperform 2
$69.31 Buy/Sell $80.99 19.75%
AMGN Stock Forecast Amgen Inc Hold 7
$241.75 Buy/Sell $268.00 14.99%
MDT Stock Forecast Medtronic Outperform 11
$80.62 Buy/Sell $90.05 6.67%

AstraZeneca PLC Free Cash Flow Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's Free Cash Flow has increased by 144.82% In the last two years, going from £1.99B to £4.87B. According to 0 analysts, AstraZeneca PLC's Free Cash Flow will fall by 30.20% in the next year, reaching £3.40B. Professionals believe that By 2030, AstraZeneca PLC's Free Cash Flow will fall to £3.69B – a 24.28% decrease from its current value.

2022 FCF Forecast
£3.40B
2023 FCF Forecast
£3.10B
2024 FCF Forecast
£3.43B
2025 FCF Forecast
£3.93B
2026 FCF Forecast
£3.76B
2027 FCF Forecast
£3.54B
2028 FCF Forecast
£3.52B
2029 FCF Forecast
£3.65B
2030 FCF Forecast
£3.69B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
CSL Stock Forecast CSL Outperform 8
$288.30 Buy/Sell $231.47 -21.59%
MRK Stock Forecast MERCK Kommanditgesellschaft au... Outperform 10
171.55€ Buy/Sell 208.74€ 22.41%
GILD Stock Forecast Gilead Sciences Inc Outperform 11
$83.00 Buy/Sell $87.30 6.02%

AstraZeneca PLC Net Income Forecast for 2023 - 2025 - 2030

In the last two years, AstraZeneca PLC's Net Income has gone down from £1.34B to £112.00M – a 91.61% drop. For next year, the 0 analysts predict Net Income of £2.15B, which would mean an increase of 1816.30%. Over the next nine years, the pros' prediction is Net Incomeof £402.18B, which would mean a nine-year growth forecast of 358988.24%.

2022 NI Forecast
£2.15B
2023 NI Forecast
£20.75B
2024 NI Forecast
£198.46B
2025 NI Forecast
£17.21B
2026 NI Forecast
£67.35B
2027 NI Forecast
£266.91B
2028 NI Forecast
£1070.99B
2029 NI Forecast
£270.28B
2030 NI Forecast
£402.18B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BDX Stock Forecast Becton, Dickinson and Outperform 17
$247.48 Buy/Sell $268.00 11.12%
GSK Stock Forecast GSK Hold 16
£1.43k Buy/Sell £16.95 -98.87%
MRNA Stock Forecast Moderna Outperform 11
$153.58 Buy/Sell $0.00 39.02%

AstraZeneca PLC EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, AstraZeneca PLC's EBITDA has grown, increasing from £5.65B to £8.37B – a growth of 48.27%. In the following year, 0 experts forecast that AstraZeneca PLC's EBITDA will decrease by 18.32%, to £6.84B. In 2030, professionals predict that AstraZeneca PLC's EBITDA will decrease by 15.98%, to £7.04B.

2022 EBITDA Forecast
£6.84B
2023 EBITDA Forecast
£6.54B
2024 EBITDA Forecast
£6.71B
2025 EBITDA Forecast
£7.25B
2026 EBITDA Forecast
£7.12B
2027 EBITDA Forecast
£6.93B
2028 EBITDA Forecast
£6.86B
2029 EBITDA Forecast
£6.99B
2030 EBITDA Forecast
£7.04B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4568 Stock Forecast Daiichi Sankyo Company Outperform 18
¥4.07k Buy/Sell ¥0.00 35.30%
BAYN Stock Forecast Bayer Outperform 7
58.72€ Buy/Sell 74.54€ 28.58%
BAS Stock Forecast BASF Hold 11
48.36€ Buy/Sell 53.50€ 13.73%

AstraZeneca PLC EBIT Forecast for 2023 - 2025 - 2030

In the last two years, AstraZeneca PLC's EBIT has grown by 46.16%, from £3.13B to £4.57B. 0 analysts predict AstraZeneca PLC's EBIT will decrease by 14.35% in the next year, reaching £3.91B. By 2030, professionals predict that AstraZeneca PLC's EBIT will decrease by 12.65%, to £3.99B.

2022 EBIT Forecast
£3.91B
2023 EBIT Forecast
£3.69B
2024 EBIT Forecast
£3.86B
2025 EBIT Forecast
£4.09B
2026 EBIT Forecast
£4.04B
2027 EBIT Forecast
£3.92B
2028 EBIT Forecast
£3.90B
2029 EBIT Forecast
£3.97B
2030 EBIT Forecast
£3.99B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4519 Stock Forecast Chugai Pharmaceutical Hold 18
¥3.31k Buy/Sell ¥0.00 36.03%
LONN Stock Forecast Lonza Group Ltd Outperform 16
CHF457.90 Buy/Sell CHF756.46 71.98%
BIIB Stock Forecast Biogen Inc Outperform 11
$278.03 Buy/Sell $322.44 16.89%

AstraZeneca PLC EPS Price Prediction Forecast for 2023 - 2025 - 2030

AstraZeneca PLC's EPS has grown in the last two years, jumping from £3.50 to £5.29 – an increase of 51.14%. In the following year, 0 experts forecast AstraZeneca PLC's EPS will decrease by 20.32%, to £4.22. In 2030, professionals predict that AstraZeneca PLC's EPS will decrease by 17.59%, to £4.36.

2022 EPS Forecast
£4.22
2023 EPS Forecast
£4.05
2024 EPS Forecast
£4.13
2025 EPS Forecast
£4.51
2026 EPS Forecast
£4.41
2027 EPS Forecast
£4.30
2028 EPS Forecast
£4.24
2029 EPS Forecast
£4.33
2030 EPS Forecast
£4.36
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BNTX Stock Forecast BioNTech Outperform 12
$150.09 Buy/Sell $0.00 32.12%
ILMN Stock Forecast Illumina Inc Outperform 16
$232.55 Buy/Sell $254.08 7.29%
4503 Stock Forecast Astellas Pharma Outperform 18
¥1.92k Buy/Sell ¥0.00 24.74%